Clinical Trial Update: Passiflora Extract for Benzodiazepine Withdrawal [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating Passiflora extract for benzodiazepine withdrawal has an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benzodiazepine Withdrawal Disorder

Drugs mentioned

• Passiflora extract

Snippet

Sponsor: Nutricion Medica S.L. | Conditions: Benzodiazepine Withdrawal (Disorder) | Phase 4 | Status: UNKNOWN